UK’s stem cell transplant system may be putting lives at risk, report by MPs finds
Summary
A UK parliamentary report found that the country’s system for stem cell transplants, used to treat blood cancer and other diseases, is not working well and may put patients' lives at risk. The report highlights weak infrastructure, poor long-term planning, and serious inequalities for people from minority ethnic backgrounds who struggle more than others to find matching donors.Key Facts
- About 4,000 stem cell transplants happen each year in the UK to treat serious diseases like blood cancer.
- Only 24% of stem cell transplants in 2024-25 used donors from the UK, while experts say 45% should come from UK donors.
- Transplants using donors from abroad are more expensive and have risks linked to the supply chain.
- Minority ethnic patients have a 37% chance of finding a well-matched donor, compared to 72% for white patients from northern Europe.
- No single UK organization is in charge of stem cell donation policy, causing delays and scattered changes.
- The All-Party Parliamentary Group (APPG) calls for a government review to fix the system.
- Charity groups and campaigners emphasize the need to improve donor registries and reduce inequalities for minority groups.
- The UK Department of Health and Social Care has not yet commented on the report.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.